BioWorld

July 18, 2003

View Archived Issues

Alteon's ALT-711 Phase II Misses; Confirmatory Trial Being Planned

Read More

Roche Scientists Find Pill That Manages Insulin, Blood Sugar In Pancreatic Islets, Liver GK Cells

Read More

Tercica Reels In $44M In Series B Funding For IGF-1 Product Launch

Read More

PPD Expands Into Device Sector, Spins Off Functional Genomics

Read More

Other News To Note

Read More

Clarification

Read More

ArQule Plans $25M Acquisition Of Cyclis To Build R&D Program

Through its planned $25 million purchase of Cyclis Pharmaceuticals Inc., ArQule Inc. will combine a biology-based program with its chemistry-focused technology to build its own research and development business. (BioWorld Today) Read More